Skip to main content

Walker Marlan D's Form 4 filing

TherapeuticsMD, Inc. (TXMD) · filed Dec 9, 2022

Accession no.
0001209191-22-060587
Filed
Dec 9, 2022
Trade date
Dec 6, 2022
Filing delay
3 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $5.19K. It was filed 3 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Walker Marlan DCIK 0001820187Officer (General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 6, 2022Common StockMOption exerciseAcquired+1,010$0.00$06,189Direct
Dec 6, 2022Common StockMOption exerciseAcquired+1,156$0.00$07,345Direct
Dec 6, 2022Common StockMOption exerciseAcquired+388$0.00$07,733Direct
Dec 6, 2022Common StockSSaleDisposed−1,048$4.95−$5,187.66,685Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 6, 2022Common StockMOption exerciseDisposed−1,010$0.00$01,010Direct
Dec 6, 2022Common StockMOption exerciseDisposed−1,156$0.00$02,311Direct
Dec 6, 2022Common StockMOption exerciseDisposed−388$0.00$0770Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)